Dr Mike Boggild

Dr Mike Boggild has over 20 years experience in neurology, initially as a consultant neurologist at The Walton Centre in Liverpool, UK before becoming Director of Neurology at The Townsville Hospital in 2012. He has a specialist interest in Multiple Sclerosis (MS) and was the visiting neurologist to The Isle of Man for 15 years with experience across the range of neurological disorders.

After completing his neurology training in Leicester, Stoke-on-Trent and Newcastle-upon-Tyne he undertook a sabbatical at MS centres in the United States before setting up the MS service in Liverpool in 1996. The Walton multi-disciplinary MS service was later recognised by the MS society as the best comprehensive service in UK. He initiated a number of investigator led clinical studies in addition to participating in numerous multi-centre trials. In 2002 he was appointed as clinical lead and subsequently chief investigator for the 5,000 patient UK MS risk-sharing scheme; a prospective 10 year study of the long-term outcomes and cost-effectiveness of disease modifying therapies, a role he relinquished in 2012 on moving to Australia.

He maintains a number of active research collaborations, most recently with academics at JCU and contributed to 2014 Australia/New Zealand guidelines on MS management. He has authored over 50 peer reviewed publications and speaks regularly at national and international meetings and symposia. He is a member of the Scientific Advisory Committee to the Australia and New Zealand Association of Neurologists (ANZAN).


Specialist Qualifications

  • MB ChB Bachelor of Medicine and Bachelor of Surgery (University of Leicester) 1986
  • MRCP (London) (Royal College of Physicians, UK) 1989
  • MD (Leicester) 1994
  • FRACP 2013


  • Royal College of Physicians (UK)
  • Association of British Neurologists (ABN)
  • Australia and New Zealand Association of Neurologists (ANZAN)
  • Royal Australian College of Physicians

Recent Publications